Trial Details
COMPLETEDBasic Information
| Clinical ID | c1697 |
|---|---|
| Identifier | NCT04090411 |
| Trial Title | A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderate to Severe Ulcerative Colitis |
| Interventions | DRUG: Induction- PF-06480605 50 mg SC Q4W|DRUG: Induction- PF-06480605 150 mg SC Q4W|DRUG: Induction- PF-06480605 450 mg SC Q4W|OTHER: Induction- Placebo SC Q4W|DRUG: Chronic- PF-06480605 50 mg SC Q4W|DRUG: Chronic- PF-06480605 150 mg SC Q4W|DRUG: Chronic- PF-06480605 450 mg SC Q4W |
Participant Information
| Sponsor | Hoffmann-La Roche |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-12-19 |
|---|---|
| Primary Completion Date | 2022-10-25 |
| Completion Date | 2022-10-25 |